NCT05790655 Ovarian PRP for Diminished Ovarian Reserve
| NCT ID | NCT05790655 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Generation Next Fertility |
| Condition | Diminished Ovarian Reserve |
| Study Type | INTERVENTIONAL |
| Enrollment | 230 participants |
| Start Date | 2023-10-07 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 230 participants in total. It began in 2023-10-07 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of diminished ovarian reserve * Clinical diagnosis of poor ovarian response * Women age 35-42 Exclusion Criteria: * Clinical diagnosis of premature ovarian failure * Clinical diagnosis of menopause. * Under 35 years of age * Over 42 years of age
Contact & Investigator
Jesse Hade, MD
PRINCIPAL INVESTIGATOR
Generation Next Fertility
Frequently Asked Questions
Who can join the NCT05790655 clinical trial?
This trial is open to female participants only, aged 35 Years or older, up to 42 Years, studying Diminished Ovarian Reserve. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05790655 currently recruiting?
Yes, NCT05790655 is actively recruiting participants. Contact the research team at a.broussard@generationnextfertility.com for enrollment information.
Where is the NCT05790655 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05790655 clinical trial?
NCT05790655 is sponsored by Generation Next Fertility. The principal investigator is Jesse Hade, MD at Generation Next Fertility. The trial plans to enroll 230 participants.